188 related articles for article (PubMed ID: 19158369)
1. Iron-magnesium hydroxycarbonate (fermagate): a novel non-calcium-containing phosphate binder for the treatment of hyperphosphatemia in chronic hemodialysis patients.
McIntyre CW; Pai P; Warwick G; Wilkie M; Toft AJ; Hutchison AJ
Clin J Am Soc Nephrol; 2009 Feb; 4(2):401-9. PubMed ID: 19158369
[TBL] [Abstract][Full Text] [Related]
2. Using iron-based phosphate binders in phosphate reduction and anemia improvement in patients receiving dialysis: a meta-analysis of randomized controlled trials.
Zhu Y; Rao J; Liao X; Ou J; Li W; Xue C
Int Urol Nephrol; 2021 Sep; 53(9):1899-1909. PubMed ID: 33675476
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind, placebo-controlled, dose-titration, phase III study assessing the efficacy and tolerability of lanthanum carbonate: a new phosphate binder for the treatment of hyperphosphatemia.
Joy MS; Finn WF;
Am J Kidney Dis; 2003 Jul; 42(1):96-107. PubMed ID: 12830461
[TBL] [Abstract][Full Text] [Related]
4. Dose-response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II study.
Koiwa F; Terao A
Clin Exp Nephrol; 2017 Jun; 21(3):513-522. PubMed ID: 27389681
[TBL] [Abstract][Full Text] [Related]
5. Novel iron-containing phosphate binders for treatment of hyperphosphatemia.
Schmid H; Lederer SR
Expert Opin Pharmacother; 2015; 16(14):2179-91. PubMed ID: 26293683
[TBL] [Abstract][Full Text] [Related]
6. Lanthanum carbonate effectively controls serum phosphate without affecting serum calcium levels in patients undergoing hemodialysis.
Shigematsu T;
Ther Apher Dial; 2008 Feb; 12(1):55-61. PubMed ID: 18257813
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of SBR759, a novel calcium-free, iron (III)-based phosphate binder, versus placebo in chronic kidney disease stage V Japanese patients on maintenance renal replacement therapy.
Fukagawa M; Kasuga H; Joseph D; Sawata H; Junge G; Moore A; Akiba T
Clin Exp Nephrol; 2014 Feb; 18(1):135-43. PubMed ID: 23670305
[TBL] [Abstract][Full Text] [Related]
8. Dose-finding study of bixalomer in patients with chronic kidney disease on hemodialysis with hyperphosphatemia: a double-blind, randomized, placebo-controlled and sevelamer hydrochloride-controlled open-label, parallel group study.
Akizawa T; Origasa H; Kameoka C; Kaneko Y; Kanoh H
Ther Apher Dial; 2014 Jun; 18 Suppl 2():24-32. PubMed ID: 24975892
[TBL] [Abstract][Full Text] [Related]
9. [The influence of short-term magnesium carbonate treatment on calcium-phosphorus balance in dialysis patients].
Zwiech R; Dryja P; Łacina D; Króliczak V; Chrul S; Kacprzyk F
Wiad Lek; 2011; 64(1):9-14. PubMed ID: 21812357
[TBL] [Abstract][Full Text] [Related]
10. Multicenter prospective randomized, double-blind comparative study between lanthanum carbonate and calcium carbonate as phosphate binders in Japanese hemodialysis patients with hyperphosphatemia.
Shigematsu T;
Clin Nephrol; 2008 Nov; 70(5):404-10. PubMed ID: 19000540
[TBL] [Abstract][Full Text] [Related]
11. Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial.
Dwyer JP; Sika M; Schulman G; Chang IJ; Anger M; Smith M; Kaplan M; Zeig S; Koury MJ; Blumenthal SS; Lewis JB;
Am J Kidney Dis; 2013 May; 61(5):759-66. PubMed ID: 23369827
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia.
Shigematsu T; Une Y; Ikejiri K; Kanda H; Fukagawa M; Akizawa T
Am J Nephrol; 2021; 52(6):496-506. PubMed ID: 34098559
[TBL] [Abstract][Full Text] [Related]
13. Randomized, Double-Blind, Placebo-Controlled, Withdrawal Study of Colestilan after Dose Titration in Chronic Kidney Disease Dialysis Patients with Hyperphosphatemia.
Hertel J; Locatelli F; Spasovski G; Dimkovic N; Wanner C
Nephron; 2015; 130(4):229-38. PubMed ID: 26184491
[TBL] [Abstract][Full Text] [Related]
14. Effect of MCI-196 on serum phosphate and cholesterol levels in haemodialysis patients with hyperphosphataemia: a double-blind, randomized, placebo-controlled study.
Locatelli F; Dimkovic N; Pontoriero G; Spasovski G; Pljesa S; Kostic S; Manning A; Sano H; Nakajima S
Nephrol Dial Transplant; 2010 Feb; 25(2):574-81. PubMed ID: 19736246
[TBL] [Abstract][Full Text] [Related]
15. Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden.
Hutchison AJ; Laville M;
Nephrol Dial Transplant; 2008 Nov; 23(11):3677-84. PubMed ID: 18577536
[TBL] [Abstract][Full Text] [Related]
16. Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration study.
Chen N; Wu X; Ding X; Mei C; Fu P; Jiang G; Li X; Chen J; Liu B; La Y; Hou F; Ni Z; Fu J; Xing C; Yu X; Huang C; Zuo L; Wang L; Hunter J; Dillon M; Plone M; Neylan J
Nephrol Dial Transplant; 2014 Jan; 29(1):152-60. PubMed ID: 24151017
[TBL] [Abstract][Full Text] [Related]
17. One year efficacy and safety of lanthanum carbonate for hyperphosphatemia in Japanese chronic kidney disease patients undergoing hemodialysis.
Shigematsu T;
Ther Apher Dial; 2010 Feb; 14(1):12-9. PubMed ID: 20438515
[TBL] [Abstract][Full Text] [Related]
18. [Iron-based Phosphate Binders for ESRD Patients].
Cozzolino M; Mangano M; Magagnoli L; Di Lullo L; Galassi A; Brancaccio D; Bellasi A
G Ital Nefrol; 2016; 33(4):. PubMed ID: 27545638
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients.
Cheng SC; Young DO; Huang Y; Delmez JA; Coyne DW
Clin J Am Soc Nephrol; 2008 Jul; 3(4):1131-8. PubMed ID: 18385391
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety and efficacy of a novel iron-containing phosphate binder, JTT-751, in patients receiving hemodialysis.
Yokoyama K; Akiba T; Fukagawa M; Nakayama M; Sawada K; Kumagai Y; Chertow GM; Hirakata H
J Ren Nutr; 2014 Jul; 24(4):261-7. PubMed ID: 24836401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]